Possible new target for sickle cell disease and beta thalassemia treatment identified

Harvard Medical School researchers at Boston Children's Hospital and Dana-Farber Cancer Institute have identified a new pathway that regulates the production of fetal hemoglobin, a form of hemoglobin that normally gets replaced soon after birth by adult hemoglobin.

≈